Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

The holidays can be especially tough for cancer patients, but two best friends are making the best of it by supporting each ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of ...

Oct. 18, 2024 — Researchers have developed an in vitro cancer model to investigate ... has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth.

LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for ...

Among 547 episodes of C difficile infection documented in cancer patients in Australia and Spain, 50% were severe and the ...

A new study evaluating the quadratic phenotypic optimization platform shows it can accurately predict personalized drug ...

Researchers sought to determine if HRQoL measures differ with gilteritinib compared with placebo in patients with AML.

Environmental toxins like pesticides and heavy metals can lead to blood cancer. Learn how genetics, lifestyle, and exposure ...